MedPath
FDA Approval

Levonorgestrel

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 29, 2013
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(1.5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Novel Laboratories, Inc.

793518643

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novel Laboratories, Inc.

Pharmacist Pharmaceutical, LLC

Novel Laboratories, Inc.

793518643

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel

Product Details

NDC Product Code
63704-009
Application Number
ANDA202508
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 29, 2013
Code: 5W7SIA7YZWClass: ACTIBQuantity: 1.5 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath